Polymorphisms in chemokine and receptor genes and gastric cancer risk and survival in a high risk Polish population

Scandinavian Journal of Gastroenterology

Volumn 46, Issue 3, 2011, Pages 333-340

  Gawron, Andrew J ^a   Fought, Angela J ^a   Lissowska, Jolanta ^b   Ye, Weimin ^c   Zhang, Xiao ^a   Chow, Wong Ho ^d   Beane Freeman, Laura E ^d   Hou, Lifang ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b INSTITUTE OF ONCOLOGY   (Poland)

^c KAROLINSKA INSTITUTE   (Sweden)

^d NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Chemokine; gastric cancer; single nucleotide polymorphisms; survival

Indexed keywords

CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CX3CR1; STROMAL CELL DERIVED FACTOR 1;

ADULT; AGED; ARTICLE; CANCER RISK; CANCER SURVIVAL; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENETIC VARIABILITY; GENOTYPE; HOMOZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; POLAND; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; STOMACH CANCER;

ADULT; AGED; CHEMOKINE CXCL2; FEMALE; FRAMESHIFT MUTATION; GENETIC ASSOCIATION STUDIES; GENOTYPE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; ODDS RATIO; POLAND; POLYMORPHISM, SINGLE NUCLEOTIDE; PROPORTIONAL HAZARDS MODELS; RECEPTORS, CCR2; RECEPTORS, CCR5; RECEPTORS, CHEMOKINE; RISK; STOMACH NEOPLASMS; YOUNG ADULT;

EID: 79751478831     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.3109/00365521.2010.537679     Document Type: Article

References (52)

1. Brenner H, Rothenbacher D, Arndt V. Epidemiology of stomach cancer. Methods Mol Biol 2009;472:467-77.
2. Bergman MP, Vandenbroucke-Grauls CM, Appelmelk BJ, D'Elios MM, Amedei A, Azzurri A, et al. The story so far: Helicobacter pylori and gastric autoimmunity. Int Rev Immunol 2005;24:63-91. (Pubitemid 40069748)
3. Smythies LE, Waites KB, Lindsey JR, Harris PR, Ghiara P, Smith PD. Helicobacter pylori-induced mucosal inflamma-tion is Th1 mediated and exacerbated in IL-4, but not IFN-gamma, gene-deficient mice. J Immunol 2000;165: 1022-9. (Pubitemid 30484772)
4. Correa P. The biological model of gastric carcinogenesis. IARC Sci Publ 2004;157:301-10.
5. Correa P, Houghton J. Carcinogenesis of Helicobacter pylori. Gastroenterology 2007;133:659-72. (Pubitemid 47187360)
6. Hold G, Rabkin C, Chow W-H, Smith M, Gammon M, Risch H, et al. A functional polymorphism of toll-like recep-tor 4 gene increases risk of gastric carcinoma and its pre-cursors. Gastroenterology 2007;132:905-12. (Pubitemid 46440859)
7. Mahajan R, El-Omar E, Lissowska J, Grillo P, Rabkin C, Baccarelli A, et al. Genetic variants in T helper cell type 1, 2 and 3 pathways and gastric cancer risk in a Polish popu-lation. Jpn J Clin Oncol 2008;38:626-33.
8. El-Omar E, Rabkin C, Gammon M, Vaughan T, Risch H, Schoenberg J, et al. Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorph-isms. Gastroenterology 2003;124:1193-201. (Pubitemid 36531795)
9. El-Omar EM, Carrington M, Chow WH, McColl KE, Bream JH, Young HA, et al. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 2000; 404:398-402. (Pubitemid 30164342)
10. Wu M-S, Wu C-Y, Chen C-J, Lin M-T, Shun C-T, Lin J-T. Interleukin-10 genotypes associate with the risk of gastric carcinoma in Taiwanese Chinese. Int J Cancer 2003;104: 617-23. (Pubitemid 36337262)
11. Ohyauchi M, Imatani A, Yonechi M, Asano N, Miura A, Iijima K, et al. The polymorphism interleukin 8-251 A/T influences the susceptibility of Helicobacter pylori related gastric diseases in the Japanese population. Gut 2005;54: 330-35. (Pubitemid 40299086)
12. Hou L, El-Omar EM, Chen J, Grillo P, Rabkin CS, Baccarelli A, et al. Polymorphisms in Th1-type cell-mediated response genes and risk of gastric cancer. Carcinogenesis 2007;28:118-23. (Pubitemid 44942634)
13. Machado JC, Figueiredo CU, Canedo P, Pharoah P, Carvalho R, Nabais Sr, et al. A proinflammatory genetic profile increases the risk for chronic atrophic gastritis and gastric carcinoma. Gastroenterology 2003;125:364-71. (Pubitemid 36929416)
14. Savage S, Abnet C, Mark S, Qiao Y-L, Dong Z-W, Dawsey S, et al. Variants of the IL8 and IL8RB genes and risk for gastric cardia adenocarcinoma and esophageal squa-mous cell carcinoma. Cancer Epidemiol Biomarkers Prev 2004;13:2251-7. (Pubitemid 40054325)
15. Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. Nature 2008;454:436-44.
16. Raman D, Baugher PJ, Thu YM, Richmond A. Role of chemokines in tumor growth. Cancer Lett 2007;256:137-65. (Pubitemid 47418345)
17. Suerbaum S, Michetti P. Helicobacter pylori infection. N Engl J Med 2002;347:1175-86.
18. Futagami S, Hiratsuka T, Suzuki K, Kusunoki M, Wada K, Miyake K, et al. gammadelta T cells increase with gastric mucosal interleukin (IL)-7, IL-1beta, and Helicobacter pylori urease specific immunoglobulin levels via CCR2 upre-gulation in Helicobacter pylori gastritis. J Gastroenterol Hepatol 2006;21:32-40.
19. Koizumi K, Hojo S, Akashi T, Yasumoto K, Saiki I. Chemokine receptors in cancer metastasis and cancer cell-derived chemokines in host immune response. Cancer Sci 2007;98:1652-8. (Pubitemid 47487897)
20. Ishigami S, Natsugoe S, Okumura H, Matsumoto M, Nakajo A, Uenosono Y, et al. Clinical Implication of CXCL12 Expression in Gastric Cancer. Ann Surg Oncol 2007;14:3154-8. (Pubitemid 47594282)
21. Woo IS, Hong SH, Byun JH, Kang J-H, Jeon H-M, Choi MG. Circulating stromal cell derived factor-1alpha (SDF-1alpha) is predictive of distant metastasis in gastric carcinoma. Cancer Invest 2008;26:256-61. (Pubitemid 351329003)
22. Zieker D, Konigsrainer I, Traub F, Nieselt K, Knapp B, Schillinger C, et al. PGK1 a potential marker for peritoneal dissemination in gastric cancer. Cell Physiol Biochem 2008; 21:429-36. (Pubitemid 351620296)
23. Chow WH, Swanson CA, Lissowska J, Groves FD, Sobin LH, Nasierowska-Guttmejer A, et al. Risk of stomach cancer in relation to consumption of cigarettes, alcohol, tea and coffee in Warsaw, Poland. Int J Cancer 1999;81:871-76. (Pubitemid 29249970)
24. Lissowska J, Groves FD, Sobin LH, Fraumeni JF, Nasierowska-Guttmejer A, Radziszewski J, et al. Family history and risk of stomach cancer in Warsaw, Poland. Eur J Cancer Prev 1999;8:223-27.
25. Wright M, Andreotti G, Lissowska J, Yeager M, Zatonski W, Chanock S, et al. Genetic variation in sodium-dependent ascorbic acid transporters and risk of gastric cancer in Poland. Eur J Cancer 2009;45:1824-30.
26. Navratilova Z. Polymorphisms in CCL2&CCL5 chemo-kines/chemokine receptors genes and their association with diseases. Biomed Pap Med Fac Univ Palacký Olomouc Czech Repub 2006;150:191-204.
27. Sugasawa H, Ichikura T, Tsujimoto H, Kinoshita M, Morita D, Ono S, et al. Prognostic significance of expression of CCL5/RANTES receptors in patients with gastric cancer. J Surg Oncol 2008;97:445-50. (Pubitemid 351466389)
28. Brand S, Sakaguchi T, Gu X, Colgan S, Reinecker H-C. Fractalkine-mediated signals regulate cell-survival and immune-modulatory responses in intestinal epithelial cells. Gastroenterology 2002;122:166-77. (Pubitemid 34049205)
29. Futagami S, Tatsuguchi A, Hiratsuka T, Shindo T, Horie A, Hamamoto T, et al. Monocyte chemoattractant protein1 and CD40 ligation have a synergistic effect on vascular endothe-lial growth factor production through cyclooxygenase 2 upre-gulation in gastric cancer. J Gastroenterol 2008;43:216-24. (Pubitemid 351486683)
30. Chow WH, Blaser MJ, Blot WJ, Gammon MD, Vaughan TL, Risch HA, et al. An inverse relation between cagA+ strains of Helicobacter pylori infection and risk of esophageal and gastric cardia adenocarcinoma. Cancer Res 1998;58:588-90. (Pubitemid 28099460)
31. Balistreri CR, Caruso C, Grimaldi MP, Listà F, Vasto S, Orlando V, et al. CCR5 receptor: biologic and genetic implications in age-related diseases. Ann NY Acad Sci 2007;1100:162-72. (Pubitemid 47092648)
32. Coelho A, Matos A, Catarino R, Pinto D, Pereira D, Lopes C, Medeiros R. Protective role of the polymorphism CCR2-64I in the progression from squamous intraepithelial lesions to invasive cervical carcinoma. Gynecol Oncol 2005; 96:760-64. (Pubitemid 40255498)
33. Coelho A, Matos A, Catarino R, Pinto D, Sousa H, Pereira D, Medeiros R. The influence of chemokine receptor CCR2 genotypes in the route to cervical carcinogenesis. Gynecol Obstet Invest 2007;64:208-12. (Pubitemid 350099006)
34. Zafiropoulos A, Crikas N, Passam AM, Spandidos DA. Significant involvement of CCR2-64I and CXCL12-3a in the development of sporadic breast cancer. J Med Genet 2004;41:e59.
35. Packer B, Yeager M, Burdett L, Welch R, Beerman M, Qi L, et al. SNP500Cancer: a public resource for sequence validation, assay development, and frequency analysis for genetic variation in candidate genes. Nucleic Acids Res 2006;34:D617-21.
36. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005;21:263-5. (Pubitemid 40202029)
37. Schaid D. Evaluating associations of haplotypes with traits. Genet Epidemiol 2004;27:348-64. (Pubitemid 39602319)
38. Schaid D. Linkage disequilibrium testing when linkage phase is unknown. Genetics 2004;166:505-12. (Pubitemid 38364735)
39. Lan Q, Chow WH, Lissowska J, Hein DW, Buetow K, Engel LS, et al. Glutathione S-transferase genotypes and stomach cancer in a population-based case-control study in Warsaw, Poland. Pharmacogenetics 2001;11: 655-61. (Pubitemid 33078234)
40. Apostolakis S, Amanatidou V, Papadakis E, Spandidos D. Genetic diversity of CX3CR1 gene and coronary artery disease: new insights through a meta-analysis. Atherosclero-sis 2009;207:8-15.
41. Chang CC, Chen SC, Hsieh YH, Chen YC, Chen TY, Chu YH, et al. Stromal cell-derived factor-1 but not its receptor, CXCR4, gene variants increase susceptibility and pathological development of hepatocellular carcinoma. Clin Chem Lab Med 2009;47:412-18.
42. Parczewski M, Leszczyszyn-Pynka M, Kaczmarczyk M, Adler G, Binczak-Kuleta A, Loniewska B, et al. Sequence variants of chemokine receptor genes and susceptibility to HIV-1 infection. J Appl Genet 2009;50:159-66.
43. Reiche EM, Bonametti AM, Voltarelli JC, Morimoto HK, Watanabe MA. Genetic polymorphisms in the chemokine and chemokine receptors: impact on clinical course and therapy of the human immunodeficiency virus type 1 infec-tion (HIV-1). Curr Med Chem 2007;14:1325-34. (Pubitemid 46746363)
44. Wang G, Yu D, Tan W, Zhao D, Wu C, Lin D. Genetic polymorphism in chemokine CCL22 and susceptibility to Helicobacter pylori infection-related gastric carcinoma. Cancer 2009;115:2430-37.
45. Liou J-M, Lin J-T, Huang S-P, Wu C-Y, Wang H-P, Lee Y-C, et al. RANTES-403 polymorphism is associated with reduced risk of gastric cancer in women. J Gastroenterol 2008;43:115-23. (Pubitemid 351344553)
46. Krauss-Etschmann S, Sammler E, Koletzko S, Konstantopoulos N, Aust D, Gebert B, et al. Chemokine receptor 5 expression in gastric mucosa of Helicobacter pylori-infected and noninfected children. Clin Diagn Lab Immunol 2003;10:22-9. (Pubitemid 36133825)
47. Conti I, Rollins B. CCL2 (monocyte chemoattractant pro-tein-1) and cancer. Semin Cancer Biol 2004;14:149-54. (Pubitemid 38586739)
48. Nakayama E, Tanaka Y, Nagai Y, Iwamoto A, Shioda T. A CCR2-V64I polymorphism affects stability of CCR2A isoform. AIDS 2004;18:729-38. (Pubitemid 38535000)
49. Sanders SK, Crean SM, Boxer PA, Kellner D, LaRosa GJ, Hunt SW. Functional differences between monocyte che-motactic protein-1 receptor A and monocyte chemotactic protein-1 receptor B expressed in a Jurkat T cell. J Immunol 2000;165:4877-83.
50. Giuntoli RN, Webb T, Zoso A, Rogers O, Diaz-Montes T, Bristow R, Oelke M. Ovarian cancer-associated ascites demonstrates altered immune environment: implications for antitumor immunity. Anticancer Res 2009;29:2875-84.
51. Negus R, Stamp G, Relf M, Burke F, Malik S, Bernasconi S, et al. The detection and localization of mono-cyte chemoattractant protein-1 (MCP-1) in human ovarian cancer. J Clin Invest 1995;95:2391-6.
52. Ohta M, Kitadai Y, Tanaka S, Yoshihara M, Yasui W, Mukaida N, et al. Monocyte chemoattractant protein-1-expression correlates with macrophage infiltration and tumor vascularity in human gastric carcinomas. Int J Oncol 2003; 22:773-8.